Exchange: OTC·Updated 01:01 PM EDT

NAVB Navidea Biopharmaceuticals Inc

$0.0001
$0.0399
(99.75%)
Today
Reported EarningsMar 21
Mkt Cap$10,008.00
Vol19,439.00

About NAVB

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Columbus, OH.
17

Extremely Bearish Sentiment

How do you feel about NAVB?

Advertisement|Remove ads.